共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
3.
4.
Imoto S Sugiyama K Yamamoto T Matsuda T 《Biochemical and biophysical research communications》2004,319(1):275-282
Bone morphogenetic proteins (BMPs) play central roles in differentiation, development, and physiologic tissue remodeling. Recently, we have demonstrated that a protein inhibitor of activated STAT, PIASy, suppresses TGF-beta signaling by interacting with Sma and MAD-related protein 3 (Smad3). In this study, we examined a PIASy-dependent inhibitory effect on BMP signaling. PIASy expression was induced by BMP-2 stimulation and suppressed BMP-2-dependent Smad activity in hepatoma cells. Furthermore, BMP-2-regulated Smads directly bound to PIASy. We also demonstrated that the RING domain of PIASy played an important role in PIASy-mediated suppression of Smad activity. We here provide evidence that the inhibitory action of PIASy on BMP-regulated Smad activity was due to direct physical interactions between Smads and PIASy through its RING domain. 相似文献
5.
Gonadotropin releasing hormone analogues (GnRHa) are often used to regress endometriosis implants and prevent premature luteinizing
hormone surges in women undergoing controlled ovarian stimulation. In addition to GnRH central action, the expression of GnRH
and receptors in the endometrium implies an autocrine/paracrine role for GnRH and an additional site of action for GnRHa.
To further examine the direct action of GnRH (Leuprolide acetate) in the endometrium, we determined the effect of GnRH on
endometrial stromal (ESC) and endometrial surface epithelial (HES) cells expression and activation of Smads (Smad3, -4 and
-7), intracellular signals activated by transforming growth factor beta (TGF-beta), a key cytokine expressed in the endometrium.
The results show that GnRH (0.1 microM) increased the expression of inhibitory Smad7 mRNA in HES with a limited effect on
ESC, while moderately increasing the common Smad4 and Smad7 protein levels in these cells (P < 0.05). GnRH in a dose- (0.01
to 10 microM) and time- (5 to 30 min) dependent manner decreased the rate of Smad3 activation (phospho-Smad3, pSmad3), and
altered Smad3 cellular distribution in both cell types. Pretreatment with Antide (GnRH antagonist) resulted in further suppression
of Smad3 induced by GnRH, with Antide inhibition of pSmad3 in ESC. Furthermore, co-treatment of the cells with GnRH + TGF-beta,
or pretreatment with TGF-beta type II receptor antisense to block TGF-beta autocrine/paracrine action, in part inhibited TGF-beta
activated Smad3. In conclusion, the results indicate that GnRH acts directly on the endometrial cells altering the expression
and activation of Smads, a mechanism that could lead to interruption of TGF-beta receptor signaling mediated through this
pathway in the endometrium. 相似文献
6.
Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation 总被引:10,自引:0,他引:10
下载免费PDF全文
![点击此处可从《The Journal of cell biology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Monzen K Hiroi Y Kudoh S Akazawa H Oka T Takimoto E Hayashi D Hosoda T Kawabata M Miyazono K Ishii S Yazaki Y Nagai R Komuro I 《The Journal of cell biology》2001,153(4):687-698
7.
8.
9.
10.
11.
Microtubule binding to Smads may regulate TGF beta activity 总被引:16,自引:0,他引:16
12.
13.
Tasima Haque Manuela Mandu-Hrit Frank Rauch Dominique Lauzier Maryam Tabrizian Reggie C Hamdy 《The journal of histochemistry and cytochemistry》2006,54(4):407-415
In this study we investigated the expression of bone morphogenetic protein (BMP)-signaling Smads in distraction osteogenesis (DO). Osteotomy of the right tibia was performed in 14 skeletally mature white New Zealand male rabbits. Lengthening was started 1 week later at a rate of 0.5 mm/12 hr and was maintained for 3 weeks. Expression of Smad proteins 1, 4, 5, 6, 7, and 8 and Smad ubiquitin regulatory factors (Smurfs) 1 and 2 was evaluated in the distracted zone using immunohistochemistry. Expression of receptor-regulated Smads (R-Smads) 1, 5, and 8 showed a significant increase during the distraction phase, followed by a gradual decrease during the consolidation phase. Smad 4 showed significant expression during both distraction and the beginning of the consolidation phase. Smad 6 and Smad 7 were highly expressed during the consolidation phase. Staining for both Smurfs 1 and 2 was maximal at the end of the distraction period. Staining for all proteins was most intense in chondrocyte and fibroblast-like cells. Expression pattern of R-Smads correlated with our previously reported expression pattern of BMPs 2, 4, and 7 and their receptors. These results therefore suggest a role for the whole BMP signaling pathway including the Smad proteins in DO. 相似文献
14.
15.
16.
Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4 总被引:15,自引:0,他引:15
Lin X Liang M Liang YY Brunicardi FC Melchior F Feng XH 《The Journal of biological chemistry》2003,278(21):18714-18719
17.
Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation 总被引:13,自引:0,他引:13
Ebisawa T Fukuchi M Murakami G Chiba T Tanaka K Imamura T Miyazono K 《The Journal of biological chemistry》2001,276(16):12477-12480
Smad7 is an inhibitory Smad that acts as a negative regulator of signaling by the transforming growth factor-beta (TGF-beta) superfamily proteins. Smad7 is induced by TGF-beta, stably interacts with activated TGF-beta type I receptor (TbetaR-I), and interferes with the phosphorylation of receptor-regulated Smads. Here we show that Smurf1, an E3 ubiquitin ligase for bone morphogenetic protein-specific Smads, also interacts with Smad7 and induces Smad7 ubiquitination and translocation into the cytoplasm. In addition, Smurf1 associates with TbetaR-I via Smad7, with subsequent enhancement of turnover of TbetaR-I and Smad7. These results thus reveal a novel function of Smad7, i.e. induction of degradation of TbetaR-I through recruitment of an E3 ligase to the receptor. 相似文献
18.
TGF-beta signaling from receptors to the nucleus 总被引:13,自引:0,他引:13
Roberts AB 《Microbes and infection / Institut Pasteur》1999,1(15):1265-1273
19.
Lallemand F Seo SR Ferrand N Pessah M L'Hoste S Rawadi G Roman-Roman S Camonis J Atfi A 《The Journal of biological chemistry》2005,280(30):27645-27653
Smad7 functions as an intracellular antagonist in transforming growth factor-beta (TGF-beta) signaling. In addition to interacting stably with the activated TGF-beta type I receptor (TbetaRI) to prevent phosphorylation of the receptor-regulated Smads (Smad2 and Smad3), Smad7 also induces degradation of the activated TbetaRI through association with different E3 ubiquitin ligases. Using the two-hybrid screen, we identified atrophin 1-interacting protein 4 (AIP4) as an E3 ubiquitin ligase that specifically targets Smad7 for ubiquitin-dependent degradation without affecting the turnover of the activated TbetaRI. Surprisingly, we found that despite the ability to degrade Smad7, AIP4 can inhibit TGF-beta signaling, presumably by enhancing the association of Smad7 with the activated TbetaRI. Consistent with this notion, expression of a catalytic mutant of AIP4, which is unable to induce ubiquitination and degradation of Smad7, also stabilizes the TbetaRI.Smad7 complex, resulting in inhibition of TGF-beta signaling. The ability of AIP4 to enhance the inhibitory function of Smad7 independent of its ubiquitin ligase activity reveals a new mechanism by which E3 ubiquitin ligases may function to turn off TGF-beta signaling. 相似文献
20.
Hoffmann A Preobrazhenska O Wodarczyk C Medler Y Winkel A Shahab S Huylebroeck D Gross G Verschueren K 《The Journal of biological chemistry》2005,280(29):27271-27283
TAK1 (transforming growth factor-beta-activated kinase-1), a MAP3K with considerable sequence similarity to Raf-1 and MEKK-1, has been identified as a transforming growth factor-beta/bone morphogenetic protein (BMP)-activated cytosolic component of the MAPK pathways. In this investigation, the molecular interactions between TAK1 and Smad proteins were characterized as well as their influence on BMP-mediated mesenchymal cell differentiation along the osteogenic/chondrogenic pathway. In co-immunoprecipitations we found an interaction of TAK1 with all Smads tested, R-Smads Smads1-5, the co-Smad Smad4, and the inhibitory Smads (I-Smad6 and I-Smad7). Smad interaction with TAK1 takes place through their MH2 domain. This interaction is dependent on the presence of an active kinase domain in TAK1. TAK1 dramatically interferes with R-Smad transactivation in reporter assays and affects subcellular distribution of Smad proteins. Activated TAK1 also interferes with BMP-dependent osteogenic development in murine mesenchymal progenitor cells (C3H10T 1/2). A potential TAK1-mediated apoptosis process could be excluded for these cells. Both synergistic and interfering influences of TAK1 on BMP-mediated Smad-signaling have been reported previously. We suggest that TAK1 is a factor that is involved in the fine-tuning of BMP effects during osteogenic development. 相似文献